Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Exp Brain Res. 2018 Feb 9;236(4):1053–1065. doi: 10.1007/s00221-018-5197-3

Fig 1.

Fig 1

Participant’s schedule from the day of arrival through the 4 days of experimental testing is shown. It shows overnight withdrawal from anti-Parkinsonian medication. Every morning at 6 am, the stimulation settings for that day were set. Each session occurred between 9 am and 11 am. Medication and stimulation were resumed as prescribed after the testing session.